<!DOCTYPE html>
<html  >
<head>
  <!-- Site made with Mobirise Website Builder v4.12.3, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v4.12.3, mobirise.com">
  <meta name="twitter:card" content="summary_large_image"/>
  <meta name="twitter:image:src" content="assets/images/adrenalin-meta.jpg">
  <meta property="og:image" content="assets/images/adrenalin-meta.jpg">
  <meta name="twitter:title" content="Adrenalin / Epinephrin">
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1">
  <link rel="shortcut icon" href="assets/images/klemmedic-s.gif" type="image/x-icon">
  <meta name="description" content="notfallmedizin.blog, Allergie, Anaphylaxie, Adrenalin, Epinephrin,  xABCDEF, cABCDEF, xABCDE, cABCDE, ABCDE">
  
  
  <title>Adrenalin / Epinephrin</title>
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-grid.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-reboot.min.css">
  <link rel="stylesheet" href="assets/facebook-plugin/style.css">
  <link rel="stylesheet" href="assets/tether/tether.min.css">
  <link rel="stylesheet" href="assets/animatecss/animate.min.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="preload" as="style" href="assets/mobirise/css/mbr-additional.css"><link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  

</head>
<body>
  <section class="mbr-section content4 cid-rRqv2QYuZs" id="content4-6b">

    

    <div class="container">
        <div class="media-container-row">
            <div class="title col-12 col-md-8">
                <h2 class="align-center pb-3 mbr-fonts-style display-2">Epinephrin (Adrenalin)</h2>
                <h3 class="mbr-section-subtitle align-center mbr-light mbr-fonts-style display-5">Die aktuellen DGAKI Leitlinien empfehlen die Gabe von Epinephrin bei nichtreanimationspflichtigen Patienten als Medikament der 1. Wahl i.m. - also noch VOR der Etablierung eines i.v.-Zugangs. Warum macht das Sinn?</h3>
                
            </div>
        </div>
    </div>
</section>

<section class="engine"><a href="https://mobirise.info/l">free site templates</a></section><section class="mbr-section article content1 cid-rRqv2REG9C" id="content1-6c">
    
     

    <div class="container">
        <div class="media-container-row">
            <div class="mbr-text col-12 mbr-fonts-style display-7 col-md-8"><p>In älteren Empfehlungen zu allergischen Reaktionen tauchte Epinephrin eigentlich immer erst ab Stadium 3, also der Schocksymptomatik auf. Dass man in einem solchen Stadium vasoaktive Substanzen benötigt ist ja auch selbsterklärend.</p><p>Der entscheidende Vorteil von Epinephrin gegenüber Substanzen wie z.B. Akrinor® liegt zu den β(2)-vermittelten und mit steigender Dosis zunehmend α-vermittelten Wirkungen wie Bronchodilatation und Vasokonstriktion vor allem in folgendem Effekt:</p><p>β1-vermittelt steigert Adrenalin die Synthese von zyklischem 3,5-AMP und blockiert damit die Mediatorfreisetzung aus Basophilen und Mastzellen. Diese Stabilisierung hemmt die weitere Histmaminfreisetzung. Hierdurch wird die Dynamik der allergischen Reaktion entscheidend beeinflusst.</p><p>&nbsp; &nbsp; &nbsp; &nbsp;Epinephrin 0.5mg i.m. (bzw. 10µg / kg)</p><p><br></p><p>Literatur:<br><span style="font-size: 1rem;">Pfaar O et al. Allergo J Int 2014; 23: 282 – 319<br></span><span style="font-size: 1rem;">Ring J et al. Allergo J Int 2014; 23: 96 – 112<br></span><span style="font-size: 1rem;">Notfall Rettungsmed 2012 · 15:123–126<br></span><span style="font-size: 1rem;">Bastigkeit M, Medikamente in der Notfallmedizin, 8.Auflage, 274-281</span></p><p><span style="font-size: 1rem;"><br></span></p><p><span style="font-size: 1rem;">KK</span></p></div>
        </div>
    </div>
</section>

<section once="footers" class="cid-rRqv2S2lsR" id="footer6-6d">

    

    

    <div class="container">
        <div class="media-container-row align-center mbr-white">
            <div class="col-12">
                <p class="mbr-text mb-0 mbr-fonts-style display-7">
                    © Copyright 2016 • notfallmedizin.blog • KLEMM K • All Rights Reserved
                </p>
            </div>
        </div>
    </div>
</section>


  <script src="assets/web/assets/jquery/jquery.min.js"></script>
  <script src="assets/popper/popper.min.js"></script>
  <script src="assets/bootstrap/js/bootstrap.min.js"></script>
  <script src="https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.5"></script>
  <script src="https://apis.google.com/js/plusone.js"></script>
  <script src="assets/facebook-plugin/facebook-script.js"></script>
  <script src="assets/web/assets/cookies-alert-plugin/cookies-alert-core.js"></script>
  <script src="assets/web/assets/cookies-alert-plugin/cookies-alert-script.js"></script>
  <script src="assets/tether/tether.min.js"></script>
  <script src="assets/smoothscroll/smooth-scroll.js"></script>
  <script src="assets/viewportchecker/jquery.viewportchecker.js"></script>
  <script src="assets/theme/js/script.js"></script>
  
  
<input name="cookieData" type="hidden" data-cookie-customDialogSelector='null' data-cookie-colorText='#232323' data-cookie-colorBg='rgba(255, 143, 0, 0.99)' data-cookie-textButton='GOT IT!' data-cookie-colorButton='#073b4c' data-cookie-colorLink='#424a4d' data-cookie-underlineLink='false' data-cookie-text="We use cookies to track visits. We store no personal data">
   <div id="scrollToTop" class="scrollToTop mbr-arrow-up"><a style="text-align: center;"><i class="mbr-arrow-up-icon mbr-arrow-up-icon-cm cm-icon cm-icon-smallarrow-up"></i></a></div>
    <input name="animation" type="hidden">
  
</body>
</html>